Topokine Therapeutics' Unattributed VC - II Round

Topokine Therapeutics raised a round of funding on April 04, 2014. Investors include Schooner Capital.

Topokine Therapeutics is a clinical-stage biotechnology company developing therapies for dermatology and medical aesthetics. The company's lead program, XAF5 Gel, is a skin cream being developed for l…

Articles about Topokine Therapeutics' Unattributed VC - II Round: